Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients.
Hao-Chien HungPo-Jung HsuJin-Chiao LeeYu-Chao WangChih-Hsien ChengTsung-Han WuTing-Jung WuHong-Shiue ChouKun-Ming ChanWei-Chen LeeChen-Fang LeePublished in: Immunity, inflammation and disease (2020)
Our findings support evidence that qPCR is effective in detecting CMV infection provides an objective perspective in predicting posttransplant outcomes. High plasma CMV DNA load (defined as CMV qPCR ≥ 180 copies/ml or 164 IU/ml) not only indicates a hazard in developing major posttransplant complications but also associates with prolonged and refractory treatment courses.